<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Almanac of Clinical Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Almanac of Clinical Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Альманах клинической медицины</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2072-0505</issn><issn publication-format="electronic">2587-9294</issn><publisher><publisher-name xml:lang="en">Moscow Regional Research and Clinical Institute (MONIKI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16730</article-id><article-id pub-id-type="doi">10.18786/2072-0505-2023-51-038</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Ischemic injury of colon mucosa as a first manifestation of Takayasu arteritis in a young female patient: challenges in the differential diagnosis</article-title><trans-title-group xml:lang="ru"><trans-title>Ишемическое поражение слизистой оболочки толстой кишки как дебют артериита Такаясу у молодой пациентки: сложности дифференциальной диагностики</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Akhmedova</surname><given-names>Maina E.</given-names></name><name xml:lang="ru"><surname>Ахмедова</surname><given-names>Маина Эмировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Head of Admission Department; Gastroenterologist, Department of Gastroenterology</p></bio><bio xml:lang="ru"><p>заведующая приемным отделением, врач-гастроэнтеролог гастроэнтерологического отделения</p></bio><email>m.akhmedova@mknc.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0524-2514</contrib-id><name-alternatives><name xml:lang="en"><surname>Fadeeva</surname><given-names>Nina A.</given-names></name><name xml:lang="ru"><surname>Фадеева</surname><given-names>Нина Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Head of Department of Gastroenterology, Senior Research Fellow, Department of Treatment of Inflammatory Bowel Diseases; Leading Specialist; Associate Professor, Chair of Gastroenterology, Faculty of Therapy</p></bio><bio xml:lang="ru"><p>канд. мед. наук, заведующая гастроэнтерологическим отделением, ст. науч. сотр. отделения лечения воспалительных заболеваний кишечника; ведущий специалист; доцент кафедры гастроэнтерологии терапевтического факультета</p></bio><email>n.fadeeva@mknc.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Filina</surname><given-names>Diana S.</given-names></name><name xml:lang="ru"><surname>Филина</surname><given-names>Диана Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Gastroenterologist, Department of Gastroenterology</p></bio><bio xml:lang="ru"><p>врач-гастроэнтеролог гастроэнтерологического отделения</p></bio><email>d.filina@mknc.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3681-4132</contrib-id><name-alternatives><name xml:lang="en"><surname>Loranskaya</surname><given-names>Irina D.</given-names></name><name xml:lang="ru"><surname>Лоранская</surname><given-names>Ирина Дмитриевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor, Head of Chair of Gastroenterology, Faculty of Therapy</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор, заведующая кафедрой гастроэнтерологии терапевтического факультета</p></bio><email>gastromapo@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">The Loginov Moscow Clinical Scientific Center</institution></aff><aff><institution xml:lang="ru">ГБУЗ г. Москвы «Московский клинический научно-практический центр имени А.С. Логинова ДЗМ»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Research Institute for Healthcare Organization and Medical Management</institution></aff><aff><institution xml:lang="ru">ГБУ г. Москвы «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента ДЗМ»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Russian Medical Academy of Continuous Professional Education</institution></aff><aff><institution xml:lang="ru">ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-12-07" publication-format="electronic"><day>07</day><month>12</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-12-09" publication-format="electronic"><day>09</day><month>12</month><year>2023</year></pub-date><volume>51</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>355</fpage><lpage>364</lpage><history><date date-type="received" iso-8601-date="2023-10-19"><day>19</day><month>10</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-11-20"><day>20</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Akhmedova M.E., Fadeeva N.A., Filina D.S., Loranskaya I.D.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Ахмедова М.Э., Фадеева Н.А., Филина Д.С., Лоранская И.Д.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Akhmedova M.E., Fadeeva N.A., Filina D.S., Loranskaya I.D.</copyright-holder><copyright-holder xml:lang="ru">Ахмедова М.Э., Фадеева Н.А., Филина Д.С., Лоранская И.Д.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://almclinmed.ru/jour/article/view/16730">https://almclinmed.ru/jour/article/view/16730</self-uri><abstract xml:lang="en"><p>Takayasu arteritis (TA) is a type of chronic large vessel vasculitis, which most often affects the aorta and its main branches as a kind of destructive-productive segmental aortitis and subaortic panarteritis, with possible obliteration of their orifices. Clinical picture of TA may be different depending on the nature and localization of the pathological process.</p> <p>We present a clinical case of ischemic injury of the colon mucosa in TA in a young (21 year old) female patient after she had a novel coronavirus infection (COVID-19). Due to ineffectiveness of out-patient treatment of ulcerative colitis, as well as complaints that were not meeting the diagnosis of ulcerative colitis, the patient was referred for additional examination and treatment modification in inpatient settings. Taking into account her diarrheal syndrome at the disease onset, the ileocolonoscopy results (rectal and colonic erosions), the results of histological examination (diffuse leukocytic infiltration of the mucosa, lymphoid infiltration of submucosa of the colon), elevation of proinflammatory markers, involvement of the inferior mesenteric artery at ultrasound dopplerography, the differential diagnosis was made between the TA overlap syndrome with inflammatory bowel diseases and TA-associated ischemic colitis. The assessment results made it possible to exclude inflammatory bowel diseases, to establish the diagnosis of TA and to consider colonic mucosa abnormalities as ischemic with underlying disease.</p> <p>The clinical case described is a rare event of intestinal ischemia as a first TA manifestation. Given the increasing worldwide prevalence of TA, especially after the new coronavirus infection pandemic, it is necessary to include this rare cause of gastrointestinal vasculitis to the differential diagnostic search, since mesenteric ischemia is one of the main causes of death in AT patients.</p></abstract><trans-abstract xml:lang="ru"><p>Артериит Такаясу (АТ) – разновидность хронического васкулита крупных сосудов, при котором чаще всего поражаются аорта и ее основные ветви по типу деструктивно-продуктивного сегментарного аортита и субаортального панартериита, с возможной облитерацией их устий. Клиническая картина АТ различается в зависимости от характера и локализации патологического процесса.</p> <p>Представляем клинический пример ишемического поражения слизистой оболочки толстой кишки при АТ у молодой женщины (21 год) после перенесенной новой коронавирусной инфекции (COVID-19). В связи с недостаточной эффективностью лечения на амбулаторном этапе язвенного колита, а также имеющимися жалобами, не укладывающимися в рамки диагноза «язвенный колит», пациентка была направлена на дообследование и коррекцию лечения в стационарных условиях. Учитывая диарейный синдром в дебюте заболевания, результаты илеоколоноскопии (эрозивное поражение прямой и толстой кишки), результаты гистологического исследования (диффузная лейкоцитарная инфильтрация слизистой оболочки, лимфоидная инфильтрация подслизистого слоя толстой кишки), повышение провоспалительных маркеров, вовлечение нижней брыжеечной артерии по данным ультразвуковой доплерографии, дифференциальный поиск проводился между оверлап-синдромом АТ с воспалительными заболеваниями кишечника и ишемическим колитом при АТ. Результаты проведенных исследований позволили исключить воспалительные заболевания кишечника, установить диагноз АТ и расценить изменения слизистой оболочки толстой кишки как ишемические на фоне основного заболевания.</p> <p>Описанное клиническое наблюдение представляет собой редкий случай ишемии кишечника в качестве первого проявления АТ. Учитывая все большее распространение АТ в мире, особенно после пандемии новой коронавирусной инфекции, необходимо включать данную редкую причину желудочно-кишечного васкулита в дифференциальный диагностический поиск, так как брыжеечная ишемия – одна из основных причин смерти у пациентов с АТ.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Takayasu arteritis</kwd><kwd>ulcerative colitis</kwd><kwd>ischemic colitis</kwd><kwd>mesenteric ischemia</kwd><kwd>COVID-19</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>артериит Такаясу</kwd><kwd>язвенный колит</kwd><kwd>ишемический колит</kwd><kwd>мезентериальная ишемия</kwd><kwd>COVID-19</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Serra R, Butrico L, Fugetto F, Chibireva MD, Malva A, De Caridi G, Massara M, Barbetta A, Cannistrà M, de Franciscis S. Updates in Pathophysiology, Diagnosis and Management of Takayasu Arteritis. Ann Vasc Surg. 2016;35:210–225. doi: 10.1016/j.avsg.2016.02.011.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Koide K. Takayasu arteritis in Japan. Heart Vessels Suppl. 1992;7:48–54. doi: 10.1007/BF01744544.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Japan Intractable Disease Information Center. Takayasu arteritis [Internet]. 2020 Mar. Japanese. Available from: https://www.nanbyou.or.jp/entry/141.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>el-Reshaid K, Varro J, al-Duwairi Q, Anim JT. Takayasu's arteritis in Kuwait. J Trop Med Hyg. 1995;98(5):299–305.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Dreyer L, Faurschou M, Baslund B. A population-based study of Takayasu's arteritis in eastern Denmark. Clin Exp Rheumatol. 2011;29(1 Suppl 64):S40–42.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Romero-Gómez C, Aguilar-García JA, García-de-Lucas MD, Cotos-Canca R, Olalla-Sierra J, García-Alegría JJ, Hernández-Rodríguez J. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies. Clin Exp Rheumatol. 2015;33(2 Suppl 89):S11–18.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Watts R, Al-Taiar A, Mooney J, Scott D, Macgregor A. The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford). 2009;48(8):1008–1011. doi: 10.1093/rheumatology/kep153.</mixed-citation></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Suvanov BS, Shalin VV, Viryasova AA, Terichev AE, Viryasov≈DV, Babushkin IO, Ufaeva TV, Tyurina OA. [Takayasu’s arteritis: a relevant problem in modern rheumatology (a literature review)]. Siberian Medical Review. 2022;(1):5–14. Russian. doi: 10.20333/25000136-2022-1-5-14.</mixed-citation><mixed-citation xml:lang="ru">Суванов БС, Шалин ВВ, Вирясова АА, Теричев АЕ, Вирясов ДВ, Бабушкин ИО, Уфаева ТВ, Тюрина ОА. Артериит Такаясу – актуальная проблема современной ревматологии (обзор литературы). Сибирское медицинское обозрение. 2022;(1):5–14. doi: 10.20333/25000136-2022-1-5-14.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><mixed-citation>Alibaz-Oner F, Aydin SZ, Direskeneli H. Advances in the diagnosis, assessment and outcome of Takayasu's arteritis. Clin Rheumatol. 2013;32(5):541–546. doi: 10.1007/s10067-012-2149-3.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Misra DP, Krishnan N, Gochhait D, Emmanuel D, Negi VS. Takayasu arteritis (TA) first presenting with intestinal ischemia: a case report and review of gastrointestinal tract involvement (ischemic and non-ischemic) associated with TA. Rheumatol Int. 2017;37(1):169–175. doi: 10.1007/s00296-016-3600-6.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83. doi: 10.1016/j.jaut.2014.01.012.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Gudbrandsson B, Molberg Ø, Garen T, Palm Ø. Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population-Based Cohort Resident in Southern Norway. Arthritis Care Res (Hoboken). 2017;69(2):278–285. doi: 10.1002/acr.22931.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Arnaud L, Haroche J, Limal N, Toledano D, Gambotti L, Chalumeau NC, Boutin DLTH, Cacoub P, Cluzel P, Koskas F, Kieffer E, Piette JC, Amoura Z. Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Medicine (Baltimore). 2010;89(1):1–17. doi: 10.1097/MD.0b013e3181cba0a3.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Karageorgaki ZT, Bertsias GK, Mavragani CP, Kritikos HD, Spyropoulou-Vlachou M, Drosos AA, Boumpas DT, Moutsopoulos HM. Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol. 2009;27(1 Suppl 52): S33–39.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Soto ME, Espinola N, Flores-Suarez LF, Reyes PA. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008;26(3 Suppl 49):S9–15.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Danda D, Luqmani RA, Watts RA, Merkel PA; DCVAS Study Group. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis. 2022;81(12):1654–1660. doi: 10.1136/ard-2022-223482.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses. 2019;11(8):762. doi: 10.3390/v11080762.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Halpert G, Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun Rev. 2020;19(12):102695. doi: 10.1016/j.autrev.2020.102695.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Spampinato S, Di Marco M, Mammolito L, Scarfia A, Valastro M, Di Mauro S, Bosco G, Purrello F, Piro S. Is COVID-19 All That Glitters? J Clin Med. 2023;12(7):2552. doi: 10.3390/jcm12072552.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Mendes JL, Venade G, Manuel P, Costa Matos L, Nascimento E. Virus and Autoimmunity: Can SARS-CoV-2 Trigger Large Vessel Vasculitis? Eur J Case Rep Intern Med. 2022;9(8):003486. doi: 10.12890/2022_003486.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Guliyeva V. 69 Large vessel vasculitis occurring after COVID-19 infection: 2 Takayasu cases. Rheumatology (Oxford). 2022;61(Suppl 2):keac496.065. doi: 10.1093/rheumatology/keac496.065.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Salman R, Masand P, Huisman TAGM, Pereira M, Kearney DL, Guillerman RP, Jadhav S. A Novel Large-Vessel Arteritis in SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children (MIS-C). Radiol Cardiothorac Imaging. 2021;3(1):e200535. doi: 10.1148/ryct.2020200535.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79(1):19–30. doi: 10.1136/annrheumdis-2019-215672.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54 Suppl:S155–163. doi: 10.1016/s0167-5273(96)02813-6.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Mirouse A, Biard L, Comarmond C, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Cacoub P, Mirault T, Resche-Rigon M, Saadoun D; French Takayasu network. Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients. J Autoimmun. 2019;96:35–39. doi: 10.1016/j.jaut.2018.08.001.</mixed-citation></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Repnikova RV, Shtark AE. [Erosive ulcerative intestinal ischemia]. Fundamental and Clinical Medicine. 2019;4(1):100–105. Russian.</mixed-citation><mixed-citation xml:lang="ru">Репникова РВ, Штарк АЭ. Эрозивно-язвенный вариант хронической ишемической болезни органов пищеварения. Фундаментальная и клиническая медицина. 2019;4(1):100–105.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><mixed-citation>Natraj Setty HS, Vijaykumar JR, Nagesh CM, Patil SS, Jadav S, Raghu TR, Manjunath CN. Takayasu’s arteritis – a comprehensive review. J Rare Dis Res &amp; Treat. 2017;2(2):63–68. doi: 10.29245/2572-9411/2017/2.1048.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Irfan M, Rehman MH, Assamullah, Ullah H, Toru HK. A rare case study, Takayasu's arteritis presentation with alopecia areata. The Stetho. 2021;2(9). Retrieved from https://thestetho.com/index.php/ts/article/view/39.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>de Almeida Martins C, Caon AER, Facanali CBG, Sobrado CW, Nahas SC, Pereira RMR, Margalit-Yehuda R, Kopylov U, Queiroz NSF. Coexistence of Takayasu's Arteritis in Patients with Inflammatory Bowel Diseases. Gastroenterol Res Pract. 2021;2021:8831867. doi: 10.1155/2021/8831867.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Sharma BK, Jain S, Sagar S. Systemic manifestations of Takayasu arteritis: the expanding spectrum. Int J Cardiol. 1996;54 Suppl:S149–154. doi: 10.1016/s0167-5273(96)88784-5.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Skeik N, Hyde JR, Olson SL, Thaler CM, Abuatiyeh W, Ahmed AK, Lyon DR, Witt DR, Garberich R, Sullivan T. Nonatherosclerotic Abdominal Vasculopathies. Ann Vasc Surg. 2019;60:128–146. doi: 10.1016/j.avsg.2019.04.004.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Daryani NE, Habibi AN, Bashashati M, Keramati MR, Rafiee MJ, Ajdarkosh H, Azmi M. Takayasu's arteritis associated with Crohn's disease: a case report. J Med Case Rep. 2008;2:87. doi: 10.1186/1752-1947-2-87.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Yadav S, Dave M, Edakkanambeth Varayil J, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sweetser SR, Melton LJ 3rd, Sandborn WJ, Loftus EV Jr. A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis. Clin Gastroenterol Hepatol. 2015;13(4):731–738.e1–6; quiz e41. doi: 10.1016/j.cgh.2014.07.061.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Sharma S, Gupta A. Visceral Artery Interventions in Takayasu's Arteritis. Semin Intervent Radiol. 2009;26(3):233–244. doi: 10.1055/s-0029-1225668.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Han C, Duan C, Zhang S, Spiegel B, Shi H, Wang W, Zhang L, Lin R, Liu J, Ding Z, Hou X. Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes. Am J Gastroenterol. 2020;115(6):916–923. doi: 10.14309/ajg.0000000000000664.</mixed-citation></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Alexandrov SS, Rednikov AA, Domanin AA, Alexandrov SA. [The diversity of the clinical manifestations of Takayasu's disease]. Upper Volga Medical Journal. 2013;11(1):9–14. Russian.</mixed-citation><mixed-citation xml:lang="ru">Александров СС, Редников АА, Доманин АА, Александров СА. О многообразии клинических проявлений болезни Такаясу. Верхневолжский медицинский журнал. 2013;11(1):9–14.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Khrutskaya MS, Pankratova YY, Semenyako SV, Parfenenko TV. [Ulcerative colitis with extraintestinal manifestations]. Lechebnoe delo [Medical Care]. 2016;48(2):74–78. Russian.</mixed-citation><mixed-citation xml:lang="ru">Хруцкая МС, Панкратова ЮЮ, Семеняко СВ, Парфененко ТВ. Язвенный колит с внекишечными проявлениями. Лечебное дело. 2016;48(2):74–78.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><mixed-citation>Enç F, Yorulmaz E, Pehlivanoğlu V, Tuncer I, Kiziltaş S, Erbahçeci A. Takayasu's arteritis in a case diagnosed as Crohn's disease. Turk J Gastroenterol. 2007;18(4):250–253.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Seyahi E. Takayasu arteritis: an update. Curr Opin Rheumatol. 2017;29(1):51–56. doi: 10.1097/BOR.0000000000000343.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Sy A, Khalidi N, Dehghan N, Barra L, Carette S, Cuthbertson D, Hoffman GS, Koening CL, Langford CA, McAlear C, Moreland L, Monach PA, Seo P, Specks U, Sreih A, Ytterberg SR, Van Assche G, Merkel PA, Pagnoux C; Vasculitis Clinical Research Consortium (VCRC); Canadian Vasculitis Network (CanVasc). Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. Semin Arthritis Rheum. 2016;45(4):475–482. doi: 10.1016/j.semarthrit.2015.07.006.</mixed-citation></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Khlynova OV, Tuev AV, Vasilets LM, Kuznetsova ES. [Cardiovascular and inflammatory bowel diseases: comorbidity or polymorbidity?]. Perm Medical Journal. 2017;34(2):94–102. Russian. doi: 10.17816/pmj34294-102.</mixed-citation><mixed-citation xml:lang="ru">Хлынова ОВ, Туев АВ, Василец ЛМ, Кузнецова ЕС. Заболевания сердечно-сосудистой системы и воспалительные заболевания кишечника: коморбидность или полиморбидность? Пермский медицинский журнал. 2017;34(2):94–102. doi: 10.17816/pmj34294-102.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><mixed-citation>Rellecke P, Strauer BE. Kardiovaskuläre Manifestationen bei chronisch-entzündlichen Darmerkrankungen [Chronic inflammatory bowel disease and cardiovascular complications]. Med Klin (Munich). 2006;101 Suppl 1: 56–60. German.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Akiyama S, Fujii T, Matsuoka K, Yusuke E, Negi M, Takenaka K, Nagahori M, Ohtsuka K, Isobe M, Watanabe M. Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis. J Gastroenterol Hepatol. 2017;32(5):1011–1017. doi: 10.1111/jgh.13640.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Wada A, Higashiyama M, Hirata D, Ito S, Tanemoto R, Nishii S, Mizoguchi A, Inaba K, Sugihara N, Hanawa Y, Horiuchi K, Akita Y, Narimatsu K, Komoto S, Tomita K, Hokari R. Changes in Colonic Inflammation Related with Takayasu Arteritis during a 10-year Observation Period. Intern Med. 2022;61(4):475–480. doi: 10.2169/internalmedicine.7287-21.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Samson M, Espígol-Frigolé G, Terrades-García N, Prieto-González S, Corbera-Bellalta M, Alba-Rovira R, Hernández-Rodríguez J, Audia S, Bonnotte B, Cid MC. Biological treatments in giant cell arteritis &amp; Takayasu arteritis. Eur J Intern Med. 2018;50:12–19. doi: 10.1016/j.ejim.2017.11.003.</mixed-citation></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">Goncharova NS, Samokhvalova MV, Pakhomov AV, Zverev DA, Moiseeva OM. [Takayasu arteritis: a review]. Arterial Hypertension. 2013;19(6):478–486. Russian. doi: 10.18705/1607-419X-2013-19-6-478-476.</mixed-citation><mixed-citation xml:lang="ru">Гончарова НС, Самохвалова МВ, Пахомов АВ, Зверев ДА, Моисеева ОМ. Артериит Такаясу. Обзор литературы. Артериальная гипертензия. 2013;19(6):478–486. doi: 10.18705/1607-419X-2013-19-6-478-476.</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><mixed-citation>Park HS, Do YS, Park KB, Kim DK, Choo SW, Shin SW, Cho SK, Hyun D, Choo IW. Long term results of endovascular treatment in renal arterial stenosis from Takayasu arteritis: angioplasty versus stent placement. Eur J Radiol. 2013;82(11):1913–1918. doi: 10.1016/j.ejrad.2013.06.019.</mixed-citation></ref></ref-list></back></article>
